This study confirms that in Yogyakarta region seroprevalence of IgA anti EBV is higher among NPC relatives and individuals presenting with chronic symptoms in the head and neck area compared to regional healthy individuals. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.